5th March 2024

A 76-year-old patient admitted with metastatic prostate cancer is receiving a continuous subcutaneous infusion of hydromorphone for pain management.

A 76-year-old patient admitted with metastatic prostate cancer is receiving a continuous subcutaneous infusion of hydromorphone for pain management. The prescribed dosage is 0.004 mg/kg/hour. The patient’s weight is 70 kg. The concentration of the hydromorphone solution is 2 mg/mL.

Calculate the total volume of hydromorphone solution, in millilitres, that should be administered to the patient per day.